Pediatrix Medical Group, Inc. (MD) Stock Price & Analysis
Pediatrix Medical Group, Inc. (MD) rose 2.66% to USD 26.26 as of July 25, 2026 at 03:50 UTC, according to Nexqual real-time market data.
MD last closed at USD 25.58; the session ranged USD 25.84–26.47 on volume of 424,998 shares. Market capitalization is —, with a 52-week range of USD 11.84–27.94 (NYQ). Source: Nexqual, July 25, 2026 at 03:50 UTC.
Key Statistics (as of July 25, 2026 at 03:50 UTC)
| Price | USD 26.26 |
|---|---|
| Change | ▲ 2.66% (up) |
| Previous Close | USD 25.58 |
| Open | USD 25.84 |
| Day Range | USD 25.84 – 26.47 |
| 52-Week Range | USD 11.84 – 27.94 |
| Volume | 424,998 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (MD)
Nexqual's technical model rates MD "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 03:50 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 57.82 (neutral) |
| vs SMA50 | Above (USD 24.14) |
| MACD | 0.49 (positive) |
Analyst Ratings (MD)
Wall Street analysts rate MD "None", per Nexqual as of July 25, 2026 at 03:50 UTC.
| Consensus Rating | None |
|---|
Earnings (MD)
| Next Earnings Date | 2026-08-04 |
|---|
Source: Nexqual, July 25, 2026 at 03:50 UTC.
Financials & Fundamentals (MD)
| Total Revenue | $1.93B |
|---|---|
| Revenue Growth (YoY) | +3.90% |
| Gross Margin | +26.09% |
| Operating Margin | +9.78% |
| Profit Margin | +9.02% |
| ROE | +20.89% |
| Debt / Equity | 71.68 |
| Current Ratio | 1.33 |
| Total Cash | $328.97M |
| Total Debt | $629.72M |
| Free Cash Flow | $163.73M |
Source: Nexqual, July 25, 2026 at 03:50 UTC.
Financial Health Score (MD)
Nexqual rates Pediatrix Medical Group, Inc.'s overall financial health "Solid" across five dimensions, as of July 25, 2026 at 03:50 UTC.
| Growth | Mixed — Revenue +3.9% YoY (latest Q), slow |
|---|---|
| Profitability | Solid — Gross margin 26%, operating 10% |
| Balance Sheet | Solid — $329M cash vs $630M debt |
| Cash Flow | Solid — FCF $164M, 8% margin |
| Efficiency | Strong — ROE 21%, ROA 7.3% |
Ownership (MD)
| Insider Ownership | +2.01% |
|---|---|
| Institutional Ownership | +107.10% |
| Float | 78.85M |
| Short % of Float | +6.58% |
Source: Nexqual, July 25, 2026 at 03:50 UTC.
Leadership (MD)
Pediatrix Medical Group, Inc. is led by Mark S. Ordan (age 66), CEO & Executive Chairman, per Nexqual as of July 25, 2026 at 03:50 UTC.
| CEO & Executive Chairman | Mark S. Ordan (age 66) |
|---|---|
| Executive VP, Treasurer & CFO | Kasandra H. Rossi (age 52) |
| Executive VP & Chief Operating and Strategy Officer | D. Gregory Neeb (age 57) |
| Senior Vice President of People Services | Debra McRoberts |
| President of West Division | Kevin Pitzer |
Major Backers & Investors (MD)
Notable institutional backers of Pediatrix Medical Group, Inc. include American Century Companies Inc, Victory Capital Management Inc., Victory Portfolios-Victory Sycamore Small Company Opportunity Fund, according to Nexqual as of July 25, 2026 at 03:50 UTC.
Active Investors
| Investor | Stake |
|---|---|
| American Century Companies Inc | 6.3% |
| Victory Capital Management Inc. | 4.68% |
| Victory Portfolios-Victory Sycamore Small Company Opportunity Fund | 3.2% |
| Wasatch Advisors LP | 3.04% |
| FMR, LLC | 2.76% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 25.22% |
| Vanguard Group | 20.09% |
| Dimensional Fund Advisors | 4.7% |
| State Street | 4.11% |
| Geode Capital | 2.66% |
Source: Nexqual, July 25, 2026 at 03:50 UTC.
From Pediatrix Medical Group, Inc.'s Latest SEC 10-K Filing (filed 2026-02-19)
Key Strengths & Strategy (as disclosed to the SEC)
- We have developed significant administrative expertise relating to our practice physician services.
- Analysis of the data within our clinical data warehouses across our neonatology and other pediatric subspecialty services allows us to provide feedback to our physicians and hospital partners and to develop and implement best practices, all with the goal of improving outcomes, creating efficiencies and ensuring patient satisfaction.
- This broad perspective allows us to better anticipate future needs and opportunities. • Quality and Safety.
- We believe that these initiatives have been enhanced by our integrated national presence together with our clinical and management information systems, which are an integral component of our clinical research and education activities.
Partnerships
- We believe telehealth reduces overall healthcare spending, improves access to quality care and facilitates collaboration with specialists while improving patient engagement and satisfaction. • Acquire Physician Practice Groups.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ACHC | Acadia Healthcare Company, Inc. | USD 34.51 | ▼ 0.78% |
| USPH | U.S. Physical Therapy, Inc. | USD 74.58 | ▲ 0.27% |
| UHS | Universal Health Services, Inc. | USD 155.75 | ▲ 4.29% |
| PBH | Prestige Consumer Healthcare In | USD 49.66 | ▲ 1.31% |
| MMS | Maximus, Inc. | USD 59.67 | ▲ 3.65% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:50 UTC. This page is informational and not investment advice.